Does Coq10 Sleep Quality Meta-Analysis work?

Updated July 2026

Quick Answer

Coq10 Sleep Quality Meta-Analysis has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Detailed information on the composition, sources, functions and other relevant details can be found in Supporting Information : Appendix S1, including figure S1, which summarises the effect of nutraceutical supplements on key biological processes in mitochondria.

Key Takeaways

  • 01Detailed information on the composition, sources, functions and other relevant details can be found in Supporting Information : Appendix S1, including figure S1, which summarises the effect of nutraceutical supplements on key biological processes in mitochondria. [Tortajada Juan (2026)]
  • 02In patients with early psychosis, Gaughran et al.found no significant differences between the vitamin D3 and placebo groups in mental health or metabolic outcomes. [Tortajada Juan (2026)]
  • 03In patients with chronic SCZ treated with clozapine, Krivoy et al.likewise found no significant effect of vitamin D3 on psychotic, depressive or metabolic parameters, although a trend towards improved cognition was reported. [Tortajada Juan (2026)]
  • 04Psychiatric disorders are complex conditions influenced by a combination of environmental and genetic factors. [Tortajada Juan (2026)]
The current Migaku evidence database contains 2 reusable source documents for Coq10 Sleep Quality Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - Detailed information on the composition, sources, functions and other relevant details can be found in Supporting Information : Appendix S1, including figure S1, which summarises the effect of nutraceutical supplements on key biological processes in mitochondria. [Tortajada Juan (2026); evidence level 1] - In patients with early psychosis, Gaughran et al.found no significant differences between the vitamin D3 and placebo groups in mental health or metabolic outcomes. [Tortajada Juan (2026); evidence level 1] - In patients with chronic SCZ treated with clozapine, Krivoy et al.likewise found no significant effect of vitamin D3 on psychotic, depressive or metabolic parameters, although a trend towards improved cognition was reported. [Tortajada Juan (2026); evidence level 1] - Psychiatric disorders are complex conditions influenced by a combination of environmental and genetic factors. [Tortajada Juan (2026); evidence level 1] - Background The study aimed to provide evidence to support optimal interventions for alleviating anxiety and depression symptoms in patients with polycystic ovarian syndrome (PCOS) through a systematic review and network meta-analysis. [Tan Z (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Clinical outcomes of mitochondrial‐enhancing nutraceutical supplementation in psychiatric disorders: A systematic review
  2. A network meta-analysis of interventions for anxiety and depression in PCOS.